Literature DB >> 23983567

Mycetoma foot.

Somnath Gooptu1, Iqbal Ali, Gurjit Singh, R N Mishra.   

Abstract

Mycetoma is an uncommon chronic granulomatous infective disease of the skin, dermis and subcutaneous tissues predominantly seen in tropical countries. A patient presented to our hospital with the swelling of the left foot with a healed sinus and a painful nodule. He gave a history of sinuses in the left foot from which there was discharge of yellow granules. Culture of the ultrasound guided fine needle aspiration cytology of the nodule revealed growths of Nocardia species. The patient was treated with a multi-drug therapy along with debridement of the painful nodule. He experienced symptomatic relief and a regression of the swelling within the three months of follow-up so far. Due to the relatively slow progression of the disease, patients are diagnosed at a late stage. Hence, emphasis should be placed on health education and the importance of wearing footwear.

Entities:  

Keywords:  Actinomycetoma; Madura foot; grains

Year:  2013        PMID: 23983567      PMCID: PMC3748649          DOI: 10.4103/2230-8229.114775

Source DB:  PubMed          Journal:  J Family Community Med        ISSN: 1319-1683


INTRODUCTION

Mycetoma is an uncommon chronic granulomatous infective disease of the skin/dermis and subcutaneous tissues. It is predominantly a disease of tropical countries and is named after the region of India (Madurai) where it was first described in 1842, also called “Madura Foot,” it is caused by true fungi (eumycetoma) or by the filamentous bacteria (actinomycetoma). It is characterized by a triad of tumefaction, draining sinuses and the presence of colonial grains in the exudates. It is seen commonly in people who walk barefoot. Eumycetoma is more common in Northern India,[1] while Actinomycetoma is more common in Southern India.[2]

CASE REPORT

A 60-year-old male living in a village about 90 km from Pune presented to our hospital with a history of generalized swelling of the left foot of about 11 months’ duration. The initial lesion had started as a single nodule over the dorsum of the foot and was followed by a second nodule that appeared two months later and a few more nodules subsequently. These lesions, mainly distributed over the dorsum of the foot [Figure 1], then burst to develop sinuses from which there was intermittent discharge of yellow colored granules. Over a period of three months, the patient developed pain in the foot that made walking difficult The left foot was grossly swollen to the ankle with healed sinuses. The clinical findings at this point were suggestive of mycetoma.
Figure 1

Dorsum of the foot showing healed and active nodules

Dorsum of the foot showing healed and active nodules Osteomyelitic changes involving the left calcaneum were seen. Since there was no discharging sinus at the time of presentation, biopsy was done from the site under ultrasound guidance and the specimen sent for staining and culture. Non-acid fast gram-positive narrow filamentous branching bacilli were seen [Figures 2 and 3]. Culture in plain Sabourauds’ dextrose agar showed growths of Nocardia species.
Figure 2

Gram stain showing colony and discharging granules (×40)

Figure 3

Gram stain showing colony and discharging granules (×100)

Gram stain showing colony and discharging granules (×40) Gram stain showing colony and discharging granules (×100) The patient was started on Trimethoprim-sulphamethoxazole (14 mg/kg, twice daily) along with Dapsone (1.5 mg/kg, twice daily) and Rifampicin (600 mg/day). The swelling decreased in size following surgical debridement of one large painful nodule. The patient has been followed up for a period of three months so far and the medication will be continued for a total period of six months or until cure is achieved.

DISCUSSION

Mycetoma is a chronic pseudotumourous infection of the skin and subcutaneous tissue, which occasionally involves the bone. It is caused by fungi (eumycetoma) or bacteria (actinomycetoma). It is endemic in the tropics and sub-tropical Africa, Mexico and India. The incidence of Mycetoma in India has been quoted between 5.2% and 35% of the mycetomas. It commonly presents between 20 years and 50 years of age, with a male to female ratio of 2.2:1.[3] Mycetoma typically presents in people who walk barefoot in dry, dusty conditions as was our case. Minor trauma causes the pathogens to enter the skin from the soil.[4] The two main groups of mycetoma are the Actinomycotic and Eumycotic groups. Actinomycetoma is caused by a group of filamentous bacteria which include Nocardia and Streptomyces species. The Nocardia species include Nocardia asteroids, Nocardia braziliensis and Nocardia caviae. The Streptomyces species include Streptomyces madurae, Streptomyces pelletieri and Streptomyces somaliensis. The color of the grains found in the discharge is indicative of the species and helps to initiate appropriate treatment. The foot is the most commonly affected and the dorsal aspect of the left foot for unexplained reasons is more affected.[5] In our patient also, the dorsal aspect of the left foot was affected. The three cardinal features of the disease are tumefaction, formation of sinus tracts and the presence of grains in the affected tissue. Our patient presented with a diffuse swelling of the left foot with a nodule and healed sinuses. In the absence of any obvious discharge as was in our case, ultrasonic imaging and fine needle aspiration from the involved area can determine the diagnosis. The simplicity of the technique, makes it useful in epidemiological survey of mycetoma and the detection of early cases in which radiological and serological techniques may be unhelpful.[6] The grains are histologically seen as sulfur granules surrounded by neutrophils which lead to a purulent tissue reaction containing fibroblasts. This prevents the antibiotic from acting on the micro-organisms, hence the need for debridement in certain cases. Our case had to undergo debridement for one large painful nodule. Mycetoma can lead to deformity, amputation and death if not treated promptly and properly.[7] Combined drug therapy is preferred to a single drug therapy to avoid resistance and any residual infection. Surgical debridement, followed by prolonged appropriate antibiotic therapy for several months is required for actinomycetoma while a combination therapy with trimethoprim-sulfamethoxazole (14 mg/kg, twice daily), dapsone (1.5 mg/kg, twice daily) and streptomycin (14 mg/kg) has been used along with Rifampicin for resistant cases. Newer antimicrobial agents like nemonoxacin, linezolid and tigecycline await clinical trials.[8] Whatever regimen is used, regular a close follow-up of patients, along with renal, hepatic and hematological assessments and evidence of ototoxicity are mandatory.[9] Our patient was treated with Trimethoprim- sulphamethoxazole, Dapsone and Rifampicin and responded to this regime. The patient refused prolonged hospitalization. Since he was from a rural area, streptomycin which is considered a first line drug in many regimes was not used. The patient is being followed-up every month for a period of 6 months and yearly thereafter to detect any recurrence. Medical management will continue until he is clinically, radiologically, ultrasonically and cytologically cured. Clinical improvements is judged by a reduction in size of the mass and the healing of most of the sinuses.[10]

CONCLUSION

Since the progression of the disease is relatively slow and pain free, patients do not report early and are therefore, diagnosed at a very late stage. Health education of vulnerable population, especially farmers in tropical countries like India, is, therefore, of the utmost importance. Furthermore to be emphasized is the importance of wearing proper footwear while working in fields. Early reporting to the primary care physicians and thereafter, an early diagnosis of the disease can lead to a decrease in morbidity.
  8 in total

1.  Negative pressure wound therapy and skin graft in madura foot treatment.

Authors:  Ali Murat Kalender; Halit Baykan; Fuat Ozkan; Harun Cıralık; Perihan Oztürk; Mustafa Gül; Hasan Uçmak
Journal:  Balkan Med J       Date:  2012-06-01       Impact factor: 2.021

2.  Environmental occurrence of Madurella mycetomatis, the major agent of human eumycetoma in Sudan.

Authors:  Abdalla Ahmed; Daniel Adelmann; Ahmed Fahal; Henri Verbrugh; Alex van Belkum; Sybren de Hoog
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

Review 3.  Mycetoma : a review.

Authors:  Vanessa Lichon; Amor Khachemoune
Journal:  Am J Clin Dermatol       Date:  2006       Impact factor: 7.403

4.  Fine needle aspiration cytology of mycetoma.

Authors:  I A EL Hag; A H Fahal; E T Gasim
Journal:  Acta Cytol       Date:  1996 May-Jun       Impact factor: 2.319

Review 5.  Mycetoma.

Authors:  M Magana
Journal:  Int J Dermatol       Date:  1984-05       Impact factor: 2.736

6.  Comparative in vitro activities of nemonoxacin, doripenem, tigecycline and 16 other antimicrobials against Nocardia brasiliensis, Nocardia asteroides and unusual Nocardia species.

Authors:  Chih-Cheng Lai; Che-Kim Tan; Sheng Hsiang Lin; Chun-Hsing Liao; Chien-Hong Chou; Hsiao-Leng Hsu; Yu-Tsung Huang; Po-Ren Hsueh
Journal:  J Antimicrob Chemother       Date:  2009-04-27       Impact factor: 5.790

7.  Actinomadura madurae causing mycetomas in Madras.

Authors:  P L Venugopal; T L Venugopal
Journal:  Indian J Pathol Microbiol       Date:  1991-04       Impact factor: 0.740

8.  Modified Welsh regimen: a promising therapy for actinomycetoma.

Authors:  D K Damle; P M Mahajan; S N Pradhan; V A Belgaumkar; A P Gosavi; S N Tolat; N R Gokhale; C B Mhaske
Journal:  J Drugs Dermatol       Date:  2008-09       Impact factor: 2.114

  8 in total
  4 in total

1.  The disabling consequences of Mycetoma.

Authors:  Mustafa Abbas; Peter Siordet Scolding; Abubaker Ahmed Yosif; Roa Fath El Rahman; Melka O El-Amin; Mohamed Kamal Elbashir; Nora Groce; Ahmed Hassan Fahal
Journal:  PLoS Negl Trop Dis       Date:  2018-12-10

2.  Cranial Mycetoma: A Rare Case Report with Review of Literature.

Authors:  Fouzia Siraj; Akanksha Malik; Sharma Shruti; K B Shankar; Swati Singh
Journal:  J Glob Infect Dis       Date:  2021-11-23

3.  Ultrasound-guided fine-needle aspiration cytology significantly improved mycetoma diagnosis.

Authors:  E E Siddig; O El Had Bakhait; M El Nour Hussein Bahar; E Siddig Ahmed; S M Bakhiet; M Motasim Ali; O Babekir Abdallah; R Ahmed Hassan; A Verbon; W W J van de Sande; A H Fahal
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-07-06       Impact factor: 9.228

Review 4.  Mycetomas: an epidemiological, etiological, clinical, laboratory and therapeutic review.

Authors:  Carmelia Matos Santiago Reis; Eugenio Galdino de Mendonça Reis-Filho
Journal:  An Bras Dermatol       Date:  2018 Jan-Feb       Impact factor: 1.896

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.